• OUTLOOK ARENA
  • VIEWS ON NEWS
  • MARCH 26, 2003

Essel Propack: Eyeing the globe

Laminated tubes major, Essel Propack, had recently reported its consolidated numbers. The company's global sales stand at around 3 bn tubes, which is 25% of the global tubes market. In year 2002 (FY03), Essel reported over 13% topline growth, but profit growth was a marginal 5%.

(Rs m) FY02 FY03 Change
Net sales 4,123 4,666 13.2%
Other Income 55 53 -3.6%
Expenditure 2,771 3,165 14.2%
Operating Profit (EBDIT) 1,352 1,501 11.0%
Operating Profit Margin (%) 32.8% 32.2%  
Interest (net) 114 111 -2.6%
Depreciation 444 556 25.2%
Profit before Tax & extraordinary items 849 887 4.5%
Tax 179 241 34.6%
Minority interest 16 40 150.0%
Extraordinary items -66 -35 -
Profit after Tax/(Loss) 620 651 5.0%
Net profit margin (%) 15.0% 14.0%  
No. of Shares (eoy) (m) 31.1 31.2  
Diluted Earnings per share* 19.9 20.9  
Current P/e ratio   6.3  
*(annualised)      

The company over the years, has acquired a global status, with presence in China, Egypt, Colombia, Venezuela, Mexico, Germany, Nepal and SE Asia. Recently the company commissioned a plant in Virginia, USA, to cater solely to P&G's laminated tube needs in the US and Mexico. Overall, going forward Essel will cater to 55% of P&G's global tube requirements, including China. For the first time, India's contribution has gone below 50% of revenues. Looking at the company's global presence, we believe this is a continuing trend.

India business (including Nepal and Egypt) recorded a marginal dip in topline. Toothpaste market has been facing tough times 2002 and the trend seems likely to continue in 2003 as well. Infact, in the December quarter, Essel's revenues dipped by 11% YoY. The company is also phasing out of Nepal owing to political disturbances in that country. Higher operating margins (owing to cost efficiencies) saw Essel posting an 18% net profit growth in FY03.

China (including Philippines) now accounts for over 30% of the company's revenues. The company has upped its market share in the region from 43% in FY02 to 50% in FY03. China region reported a 12% revenue growth and a 15% growth at the operating profit level. Essel is targeting a 60% share of this 2 bn tube market and has identified the region as its growth engine.

Europe (mainly Germany) grew by 23% in revenues. However margins in the region are not very lucrative owing to high competition. The Americas region (Colombia, Mexico and Venezuela) saw a marginal 2% growth in revenues. Here too, profitability is lower. Going forward the supplies to P&G in the US and Mexico will spearhead revenue growth from this region. However, the company has not disclosed what number of laminating tubes they are to supply to P&G.

At the current market price of Rs 132 the stock trades at 6.3x FY03 earnings. The valuations are quite low compared to Essel's earning potential and growth strategy going forward. However, sentiment towards the counter has been marred due to pomoter concerns and the fact that margins beyond Indian shores are not very lucrative.

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited (Research Analyst)
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407